Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANIK | AMGN | CELG | GILD | BIIB |
| Company | Anika Therapeutics | Amgen Inc | Celgene Corp | Gilead Sciences Inc | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 25.20 | 335.15 | 108.01 | 83.26 | 200.01 |
| High | 25.54 | 338.97 | 108.59 | 83.99 | 200.37 |
| Low | 24.82 | 334.27 | 107.27 | 82.75 | 196.96 |
| Last | 25.50 | 337.38 | 108.24 | 83.94 | 199.36 |
| Change | +0.14 | +1.43 | +0.11 | +0.04 | -2.08 |
| % Change | +0.55% | +0.43% | +0.10% | +0.05% | -1.03% |
| Volume | 399,000 | 4,068,200 | 191,230,496 | 24,925,900 | 3,833,500 |
| 20-Day Average Volume | 56,895 | 1,855,500 | 16,188,930 | 7,644,690 | 980,680 |
| Previous Close | 25.36 | 335.95 | 108.13 | 83.90 | 201.44 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | No | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 25.09 | 330.23 | 108.17 | 80.47 | 201.40 |
| 20-Day Raw Stochastic | 57.94% | 91.90% | 63.25% | 89.42% | 49.20% |
| 20-Day Relative Strength | 50.25% | 58.76% | 64.69% | 71.95% | 42.93% |
| Weighted Alpha | +30.19 | +27.84 | +46.30 | +18.32 | -22.73 |
| Today's Opinion | 8% Sell | 100% Buy | 100% Buy | 88% Buy | 100% Sell |
| Previous Opinion | 8% Sell | 96% Buy | 100% Buy | 88% Buy | 100% Sell |
| Last Month's Opinion | 24% Buy | 88% Buy | 100% Buy | 56% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.49% since 09/13/24 | +1.48% since 09/13/24 | -1.97% since 11/13/19 | +1.36% since 09/13/24 | +1.91% since 09/13/24 |
| Low | 24.59 on 09/16/24 | 331.00 on 09/18/24 | 107.27 on 11/20/19 | 82.38 on 09/17/24 | 194.75 on 09/16/24 |
| High | 26.00 on 09/18/24 | 339.00 on 09/18/24 | 110.53 on 11/14/19 | 84.65 on 09/19/24 | 204.18 on 09/19/24 |
| 1-Month | |||||
| %Chg | -0.97% since 08/20/24 | +2.69% since 08/20/24 | +5.14% since 10/18/19 | +12.29% since 08/20/24 | -2.98% since 08/20/24 |
| Low | 24.15 on 09/11/24 | 319.00 on 09/06/24 | 102.40 on 10/21/19 | 74.80 on 08/21/24 | 192.25 on 09/13/24 |
| High | 26.48 on 08/30/24 | 339.00 on 09/18/24 | 110.70 on 11/13/19 | 84.89 on 09/12/24 | 207.59 on 08/21/24 |
| 3-Month | |||||
| %Chg | -1.85% since 06/20/24 | +8.87% since 06/20/24 | +13.63% since 08/20/19 | +22.56% since 06/20/24 | -11.62% since 06/20/24 |
| Low | 24.15 on 09/11/24 | 306.11 on 07/03/24 | 93.41 on 08/23/19 | 66.01 on 07/05/24 | 192.25 on 09/13/24 |
| High | 29.11 on 07/18/24 | 346.85 on 07/25/24 | 110.70 on 11/13/19 | 84.89 on 09/12/24 | 238.00 on 07/12/24 |
| 6-Month | |||||
| %Chg | -0.35% since 03/20/24 | +23.56% since 03/20/24 | +14.14% since 05/20/19 | +13.46% since 03/20/24 | -8.61% since 03/20/24 |
| Low | 23.92 on 06/07/24 | 260.68 on 04/19/24 | 89.08 on 07/23/19 | 62.07 on 05/31/24 | 189.44 on 04/19/24 |
| High | 29.11 on 07/18/24 | 346.85 on 07/25/24 | 110.70 on 11/13/19 | 84.89 on 09/12/24 | 238.00 on 07/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 371,968 | 180,982,432 | 77,035,920 | 104,576,912 | 29,026,218 |
| Shares Outstanding, K | 14,587 | 536,435 | 711,714 | 1,245,853 | 145,597 |
| Annual Sales | 166,660,000 | 28,190,000,000 | 15,281,000,000 | 27,116,000,000 | 9,835,600,000 |
| Annual Net Income | -82,670,000 | 6,717,000,000 | 4,046,000,000 | 5,665,000,000 | 1,161,100,000 |
| Last Quarter Sales | 41,920,000 | 8,388,000,000 | 4,520,000,000 | 6,954,000,000 | 2,464,900,000 |
| Last Quarter Net Income | -90,000 | 746,000,000 | 1,691,000,000 | 1,614,000,000 | 583,600,000 |
| 60-Month Beta | 0.83 | 0.61 | 1.41 | 0.18 | -0.06 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.17 on 08/08/24 | 4.97 on 08/06/24 | 2.99 on 10/31/19 | 2.01 on 08/08/24 | 5.28 on 08/01/24 |
| Latest Earnings Date | 11/07/24 | 10/29/24 | 10/31/19 | 11/05/24 | 11/13/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 181.14 | 18.06 | 10.99 | 17.85 | 12.39 |